Psychedelic-assisted psychotherapy is a clinical model where psychotherapy is primary and a psychedelic compound is used as an adjunct within a structured treatment plan. It typically occurs in regulated settings with licensed clinicians, standardized screening, preparation, monitored dosing, and integration. Access is often limited to trials or approved programs depending on local law.
Trip therapy is an experience-centered approach offered outside the medical system. It focuses on mindset, setting, guided support, and post-session integration rather than formal psychotherapy. In places where it is legal, services may use permitted options such as psilocybin truffles in the Netherlands. It is not medical care and standards can vary by provider.
Key differences include framework and goals, credentials and oversight, legal status and access, and how preparation and integration are delivered. If you consider either path, verify provider qualifications, understand the legal context in your location, and assess your personal needs and risk tolerance. I cannot verify individual providers or outcomes.
For a Dutch example of preparation, guided sessions, and integration within a legal framework, see Triptherapie Nederland.
I hope this helps clarify the distinction.